(Q46379699)

21 December 2017

title

Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis (English)

1 reference

21 December 2017

author name string

Florence W L Tsui

1

1 reference

21 December 2017

Hing Wo Tsui

2

1 reference

21 December 2017

Facundo Las Heras

3

1 reference

21 December 2017

Kenneth P H Pritzker

4

1 reference

21 December 2017

Robert D Inman

5

1 reference

21 December 2017

language of work or name

English

0 references

publication date

26 July 2013

1 reference

21 December 2017

Annals of the Rheumatic Diseases

published in

1 reference

21 December 2017

volume

73

1 reference

21 December 2017

issue

10

1 reference

21 December 2017

page(s)

1873-1879

1 reference

21 December 2017

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

How to diagnose axial spondyloarthritis early

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Interactions between gut inflammation and arthritis/spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Structural basis of BMP signalling inhibition by the cystine knot protein Noggin

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Ankylosing spondylitis and HL-A 27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

High Association of an HL-A Antigen, W27, with Ankylosing Spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Molecular mimicry and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

IBD and arthropathies: a practical approach to its diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Serological markers predict inflammatory bowel disease years before the diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Autoimmunity's collateral damage: Gut microbiota strikes 'back'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Management of comorbidities in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

How to screen for axial spondyloarthritis in primary care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

Aberrant Chondrocyte Hypertrophy and Activation of ss-Catenin Signaling Precede Joint Ankylosis in ank/ank Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203630

10.1136/ANNRHEUMDIS-2013-203630

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017